Literature DB >> 23100939

Sickle-β(+) thalassemia with splenic calcification and bone marrow infarction: a case report.

Rakhee Kar1, Reena Das, Akshay Saxena, Y Chawla, Jasmina Ahluwalia.   

Abstract

We came across an unusual case of a 20 years old male from north India who presented with repeated episodes of pyrexia of unknown origin (PUO) and history of chronic hemolytic anemia. On investigation he was detected to have Sickle-β(+) Thalassemia and subtle features of hyposplenism. Radiological investigations revealed extensive splenic calcification and bone marrow examination to evaluate for PUO showed extensive bone marrow infarction and fibrosis. Molecular diagnosis for beta thalassemia mutation revealed heterozygosity for IVS 1-5 M and alpha globin genes were normal. This case highlights the wide variation of clinical phenotype which is encountered with Sickle-β(+) Thalassemia where genotyping can predict the clinical phenotype only partially.

Entities:  

Keywords:  Bone Marrow Infarction; Sickle-β+ Thalassemia; Splenic calcification

Year:  2008        PMID: 23100939      PMCID: PMC3453168          DOI: 10.1007/s12288-008-0021-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  11 in total

Review 1.  Pathophysiology of sickle cell disease: role of cellular and genetic modifiers.

Authors:  M H Steinberg; G P Rodgers
Journal:  Semin Hematol       Date:  2001-10       Impact factor: 3.851

2.  Perivascular fibrosis in the bone marrow in sickle cell disease.

Authors:  Elizabeth A Manci; Donald E Culberson; Julia M Gardner; Byron G Brogdon; Arvind K Shah; J Elyse Holladay; Randall W Powell; Vipul N Mankad
Journal:  Arch Pathol Lab Med       Date:  2004-06       Impact factor: 5.534

Review 3.  Overview of pathophysiology and rationale for treatment of sickle cell anemia.

Authors:  G P Rodgers
Journal:  Semin Hematol       Date:  1997-07       Impact factor: 3.851

4.  Fatal splenic sequestration crisis in adult sickle cell-beta thalassaemia.

Authors:  F van Rhee; M Balsitis; E A French
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

5.  Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.

Authors:  W N Poillon; B C Kim; G P Rodgers; C T Noguchi; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

6.  Severe Hb S-beta+ thalassemia caused by IVS-I splice site mutations.

Authors:  J Li; M Plonczynski; M H Steinberg; A Kheradpour; B P Alter
Journal:  Hemoglobin       Date:  1998-07       Impact factor: 0.849

7.  Sickle cell beta thalassemia with absence of spleen (a case report).

Authors:  J V Hardikar; S V Nadkarni
Journal:  J Postgrad Med       Date:  1983-10       Impact factor: 1.476

8.  Splenic calcifications in heterozygote sickle cell patients.

Authors:  A Ozgen; D Akata; A Arat; M Ozdogan; O Akhan; M N Ozmen
Journal:  Abdom Imaging       Date:  1999 Mar-Apr

9.  Facial bone infarcts in sickle cell syndromes.

Authors:  J E Royal; V J Harris; P K Sansi
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

Review 10.  Multiorgan failure during a sickle cell crisis in sickle/beta-thalassemia.

Authors:  Fasika M Tedla; Eli A Friedman
Journal:  Am J Kidney Dis       Date:  2003-08       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.